Weather | Traffic | Surf | Maps |


   
 
Forums Visitors Guide Shopping Classifieds Autos Homes Jobs Entertainment Sports Today's Paper Home

 News
 Metro | Latest News
 North County
 Temecula/Riverside
 Tijuana/Border
 California
 Nation
 Mexico
 World
 Obituaries
 Today's Paper
 AP Headlines
 Business
 Technology
 Biotech
 Markets
 In Depth
 Iraq / Afghanistan
 Pension Crisis
 Special Reports
 Video
 Multimedia
 Photo Galleries
 Topics
 Education
 Features
 Health | Fitness
 Military
 Politics
 Science
 Solutions
 Opinion
 Columnists
 Steve Breen
 Forums
 Weblogs
 Communities
 U-T South County
 U-T East County
 Solutions
 Calendar
 Just Fix It
 Services
 Weather
 Traffic
 Surf Report
 Archives
 E-mail Newsletters
 Wireless | RSS
 Noticias en Enlace
 Internet Access

 Sponsored Links

More Biotechnology news
A validating experience


He's buoyed by research that is a means to an end

UNION-TRIBUNE

June 17, 2008

An interest in science is what got Greg Budahazi started in the biotech industry.

After graduating from UCSD with a bachelor's degree in biochemistry, he began his biotech career in San Diego in the mid '80s, working in research and development.


EDUARDO CONTRERAS / Union-Tribune
Greg Budahazi's work as manager of purification development at Vical involves improving manufacturing techniques to find cheaper, faster and easier ways to bring drugs to market.
Budahazi worked for some smaller companies, such as Quidel, working with dip-stick testing technologies, and at Agouron (now part of Pfizer), where he helped develop the HIV treatment Viracept. He also worked in research and development at Vical for nine years.

But after a decade in the industry, Budahazi decided he wanted go in a different direction. After working with other companies, he returned to his former employer Vical three years ago in a different capacity as manager of purification development.

“I really liked process development,” he said. “It was like research, but had an end to it.”

Budahazi works with manufacturing techniques to find cheaper, easier and more time efficient ways to bring drugs to market. He develops methods to purify processes, scale up production and validate the process.

Greg Budahazi

Position: Manager of purification development

Company: Vical

Age: 50

Career highlights: Previous positions with Agouron Pharmaceuticals (now part of Pfizer) and Quidel

Education: bachelor's degree in biochemistry, University of California San Diego

“Fourteen years ago, we were excited to be making a few milligrams of product. We now manufacture 10-15 grams per production run and are capable of manufacturing larger quantities,” he said. “Having developed many of Vical's manufacturing process steps is very rewarding.”

He likes that his job “enables me to see a tangible improvement and to save the company money,” Budahazi said. “It's very satisfying to be able to say that I helped the company.”

He sees great opportunities in biotech for science graduates with a bachelor's degree. “The opportunities are broader now, so not having a Ph.D. is not limiting,” he said.

But he cautions that in smaller companies with fewer employees “career development can be challenging.”

“You have to keep yourself motivated and interested.” he said. “You have to make it happen for yourself.”








Quicklinks
Restaurants Bars
Hotels Autos
Shopping Health
Eldercare Singles
Business Listings
Free Newsletters


Guides
Vegas Spas/Salon
Travel Weddings
Wine Old Town
Baja Catering
Casino Home Imp.
Golf SD North
Gaslamp


© Copyright 1995-2009 Union-Tribune Publishing Co. • A Copley Newspaper Site